A First-in-Human Study Evaluating AGA2118 in Men and Postmenopausal Women
Clinical trial NCT05225857 · COMPLETED
Trial details
- NCT number
- NCT05225857
- Sponsor
- Angitia Biopharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-28
- Primary completion
- 2024-01-13
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.